New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
Antiretroviral therapy (ART) controls human immunodeficiency virus 1 (HIV-1) replication and prevents disease progression but does not eradicate HIV-1. The persistence of a reservoir of latently infected cells represents the main barrier to a cure. “Shock and kill” is a promising strategy involving...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2021-08-01
|
| Serija: | Viruses |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1999-4915/13/8/1560 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|